Diego Cadavid's Net Worth

$812 Thousand

Estimate Recalculated Jun 3, 2025 09:02PM EST

Who is Diego Cadavid

Diego Cadavid does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., and X4 Pharmaceuticals, Inc.

SEC CIK

Diego Cadavid's CIK is 0001778713

Past Insider Trading and Trends

2020 was Diego Cadavid's most active year for acquiring shares with 11 total transactions. Diego Cadavid's most active month to acquire stocks was the month of May. 2020 was Diego Cadavid's most active year for disposing of shares, totalling 22 transactions. Diego Cadavid's most active month to dispose stocks was the month of May. 2020 saw Diego Cadavid paying a total of $808,196.40 for 182,520 shares, this is the most they've acquired in one year. In 2020 Diego Cadavid cashed out on 16,517 shares for a total of $205,754.52, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Fulcrum Therapeutics, Inc.

SVP Clinical Development
Updated Jul 02, 2020
Form 4
-1.60%
-1.07K
$18.30
-$19.60K
Jul 02, 2020
65.71K
Sale
ScheduledJul 01
Form 4
-1.81%
-1.46K
$13.42
-$25.05K
Jun 26, 2020
79.06K
Sale
ScheduledJun 25
Form 4
-0.50%
-401.00
$13.42
-$6.89K
Jun 12, 2020
80.52K
Sale
ScheduledJun 10
Form 4
-0.83%
-677.00
$12.49
-$10.36K
Jun 08, 2020
80.92K
Sale
ScheduledJun 04 - Jun 05
Form 4
-0.47%
-383.00
$12.50
-$5.87K
Jun 04, 2020
81.60K
Sale
ScheduledJun 02 - Jun 03
Form 4
-0.97%
-800.00
$12.42
-$12.14K
Jun 01, 2020
81.98K
Sale
ScheduledMay 28 - May 29
Form 4
-2.20%
-1.86K
$11.42
-$24.50K
May 12, 2020
82.78K
Sale
ScheduledMay 12
Form 4
-3.11%
-2.14K
$17.38
-$37.25K
Mar 02, 2020
66.79K
Sale
ScheduledMar 02
Form 4
-3.02%
-2.14K
$17.33
-$37.14K
Feb 05, 2020
68.93K
Sale
ScheduledFeb 03
Form 4
55.44K
Jan 27, 2020
55.44K
Grant
Jan 23
Form 4
12.78K
Jul 18, 2019
12.78K
Grant
Jul 18
Form 3
Jul 17, 2019
71.07K
Showing 12 results

X4 Pharmaceuticals, Inc

Chief Medical Officer
Updated Mar 01, 2022
Form 4
1,364.85%
97.00K
Mar 01, 2022
104.11K
Grant
Mar 01
Form 4
-11.55%
-928.00
Feb 14, 2022
7.11K
Sale
ScheduledFeb 11
Form 4
8.04K
Mar 25, 2021
8.04K
Grant
Mar 24
Form 4
121.50K
$6.43
$781.25K
Jan 06, 2021
121.50K
Grant
Dec 31
Form 3
Dec 14, 2020
Showing 5 results